Drugs / NOSHIN SHAHD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06205030 Comparator | Sep 2025 → Jul 2027 expected | type 2 diabetes mellitus | Kerman Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NOSHIN SHAHD | “Volunteers are asked to take the received NOSHIN SHAHD drug 20 ml three times per day after food.” NCT06205030 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Efficacy of a Traditional Anti-diabetic Herbal Drug on Glycemic, Inflammatory, and Oxidative Stress Parameters in Patients With Type 2 Diabetes” NCT06205030 ↗ |
| Route | Oral | “one group will drink herbal syrup” NCT06205030 ↗ |